THE HEALTH CORPORATION - RAMBAM - Israel 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 5.997.312 215.000 1
2020 0 19.884.570 185.000 1
2019 0 6.799.100 226.444 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
ABBOTT RAPID DX INTERNATIONAL LIMITED1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELERATE DIAGNOSTICS SL1
AINIGMA TECHNOLOGIES1
ASTON UNIVERSITY1
BARMER ERSATZKASSE1
BD SWITZERLAND SARL1
BERRY CONSULTANTS LLP1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOMERIEUX1
BIORAD1
CATALYZE BV1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CHAROKOPEIO PANEPISTIMIO1
CLINIQUE PASTEUR1
CRI THE CLINICAL RESEARCH INSTITUTE1
CSI CENTER FOR SOCIAL INNOVATION1
DBC EUROPE1
DEUTSCHE HERZSTIFTUNG EV1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN RESPIRATORY SOCIETY1
EUROPEAN SOCIETY CLINICAL MICROBIOLOGY INFECTIOUS DISEASES1
EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS1
FAKULTNI NEMOCNICE OLOMOUC1
FONDAZIONE PENTA FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES ONLUS1
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUTURO PERFECTO INNOVACION SL1
GESUNDHEIT OSTERREICH1
HELIOS HEALTH INSTITUTE1
IDCQ HOSPITALES Y SANIDAD SL1
INSTITUT CURIE1
INSTITUT JULES BORDET ASBL1
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ1
ISTITUTO AUXOLOGICO ITALIANO1
JANSSEN PHARMACEUTICA NV1
JOHANNES GUTENBERG UNIVERSITAET MAINZ1
LEIPZIG HEART SCIENCE GEMEINNUTZIGEGMBH1
MCS DATALABS1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
PULSIFY MEDICAL BV1
QS INSTITUTO DE INVESTIGACION E INNOVACION SL1
REGION STOCKHOLM1
ROZENBAUM KONSULTING1
SEMMELWEIS UNIVERSITY OF MEDICINE1
SIHTASUTUS POHJAEESTI REGIONAALHAIGLA1
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH1
SOCIETE EUROPEENNE DE CARDIOLOGIE1
STICHTING NETHERLANDS HEART INSTITUTE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE TRUSTEES OF BOSTON UNIVERSITY1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF MANCHESTER1
THE WELLCOME TRUST LIMITED1
UNIVERSIDAD DE LA RIOJA1
UNIVERSITA DEGLI STUDI DI VERONA1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITAT BAYREUTH1
UNIVERSITEIT ANTWERPEN1
UNIVERSITY OF AARHUS1
UNIVERSITY OF LEEDS1
UNIVERSITY OF YORK1
ZORGONDERZOEK NEDERLAND ZON1

Constancy:

Total number of partners: 67
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 67
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal intervention, combining pain and cachexia management, nutrition, and physical activity RELEVIUMparticipant5.997.31218
2020-01-01Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction PROFIDparticipant19.884.57026
2019-04-01The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use VALUE-Dxparticipant6.799.10026